Nazli Dizman
0000-0002-3907-8513
8 papers found
Refreshing results…
Association Between Time-of-Day of Immune Checkpoint Blockade Administration and Outcomes in Metastatic Renal Cell Carcinoma
Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium
Outcomes With Combination Pembrolizumab and Axitinib in Second and Further Line Treatment of Metastatic Renal Cell Carcinoma
Genomic and Clinical Prognostic Factors in Patients With Advanced Urothelial Carcinoma Receiving Immune Checkpoint Inhibitors
Cabozantinib Safety With Different Anticoagulants in Patients With Renal Cell Carcinoma
Characterizing the relationships between tertiary and community cancer providers: Results from a survey of medical oncologists in Southern California
Complementary Role of Circulating Tumor DNA Assessment and Tissue Genomic Profiling in Metastatic Renal Cell Carcinoma
Circulating cytokines associated with clinical response to systemic therapy in metastatic renal cell carcinoma
Missing publications? Search for publications with a matching author name.